J&J Acquires Crystalline Technology Through $230 Mil. TransForm Buy
Executive Summary
Johnson & Johnson will have access to all of TransForm Pharmaceuticals' proprietary crystalline formulation technology through its proposed $230 mil. acquisition of the privately held company
You may also be interested in...
J&J TransForm acquisition (correction)
Johnson & Johnson's purchase price for TransForm Pharmaceuticals is $230 mil.; the March 14, 2005 1issue of "The Pink Sheet" mis-stated the figure...
J&J TransForm acquisition (correction)
Johnson & Johnson's purchase price for TransForm Pharmaceuticals is $230 mil.; the March 14, 2005 1issue of "The Pink Sheet" mis-stated the figure...
J&J Open To Large-Scale Mergers; Still Prefers Centocor, Alza-Sized Deals
Johnson & Johnson is open to deals larger than the $10.5 bil. Alza acquisition, CEO William Weldon said Jan. 20